Trade MGTX anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
MeiraGTx Holdings plc (MGTX) is trading at US$13.87, down 1.92% today as of Aug 28, 11:27 EDT. The company has a market capitalisation of US$1.38B. Over the past 52 weeks, MGTX has traded between US$6.62 and US$15.35. On Syfe you can trade MGTX with $0 commission and add it to your watchlist.
| Previous close | US$14.14 |
|---|---|
| Market cap | US$1.38B |
| 52-week range | US$6.62 – US$15.35 |
| Volume | 955.12K |
| Exchange | US |
Add to Watchlist
Set Price Alert
MeiraGTx Holdings plc
MeiraGTx Holdings Plc is a clinical-stage genetic medicines company with a broad pipeline of late-stage clinical programs, including Parkinson’s disease, radiation-induced xerostomia and AIPL1-associated retinal dystrophy. It targets local delivery of small doses of genetic medicines to treat both inherited and more common conditions with severe unmet needs. The company was founded on March 20, 2015 and is headquartered in New York, NY.
Year: 2018
MeiraGTx Holdings plc (MGTX) stock is trading at US$13.87, -1.92% from the previous close of US$14.14.
The market cap for MeiraGTx Holdings plc (MGTX) stock is approximately US$1.38B.
The 52-week high for MeiraGTx Holdings plc (MGTX) stock is US$15.35.
The 52-week low for MeiraGTx Holdings plc (MGTX) stock is US$6.62.
MeiraGTx Holdings plc (MGTX) does not currently pay a dividend.
Stay on top of MGTX
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
